The effect of vitamin D administration during labor on the incidence of Transient rapid breathing of the Newbor
Phase 3
- Conditions
- Transient tachypnea of newborn.Transient tachypnea of newbornP22.1
- Registration Number
- IRCT20110807007244N5
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
Pregnant mothers upper 32 weeks with delivery symptoms
Exclusion Criteria
Mothers with asthma
post term pregnancy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of transient tachypnea of newborn. Timepoint: 1-3 days after neonatal birth. Method of measurement: Clinical and radiological signs and clinical course of transient tachypnea of newborn.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link vitamin D administration during labor to reduced transient tachypnea of the newborn (TTN) incidence?
How does vitamin D supplementation during labor compare to standard-of-care in preventing TTN (P22.1) in term infants?
Which biomarkers, such as vitamin D receptor (VDR) expression, predict response to maternal vitamin D administration in preventing TTN (P22.1)?
What are the potential adverse events of vitamin D administration during labor and their management strategies in TTN (P22.1) prevention?
Are there combination therapies involving vitamin D and other maternal supplements that enhance TTN (P22.1) prevention efficacy compared to IRCT20110807007244N5?